Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The pharmaceutical company Viking has recently become one of the most volatile stocks on Wall Street due to the announcement ...

Per terms, Novo could pay up to $285 million in upfront and milestone fees to Ascendis, which specializes in a kind of drug-enhancing technology.

A new $20 million industrial park has opened in Tomball and it aims to be a new hot spot for smaller businesses.

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...

Some people who take Ozempic or Wegovy (semaglutide) are using a method called “counting clicks” or microdosing to get a little more or less medication in each shot than the standard amount ...

About 6% of Americans with obesity and without diabetes have had surgery or taken GLP-1 agonists, the research team estimates ...

Another wrote, "She's embracing the South Park joke. I love it." The "Truth Hurts" singer followed up with footage of herself dancing to the jingle from the episode's fake commercial, including a ...

Rapper and singer Lizzo’s latest take on South Park’s obesity-themed special has drawn attention from people on social media.